Загрузка...

Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection

Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii (pj) can lead to serious health consequences in patients with an immunocompromised system. Trimethoprim (TMP), used as first-line therapy in combination with sulfamethoxazole, is a selective but only moderately potent pj dihydrofolate red...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Bioorg Med Chem Lett
Главные авторы: Khushbu, Shah, Sherry, Queener, Vivian, Cody, Jim, Pace, Aleem, Gangjee
Формат: Artigo
Язык:Inglês
Опубликовано: 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588427/
https://ncbi.nlm.nih.gov/pubmed/31176699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2019.06.004
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!